C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including Cemsidomide Transcript

C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including…

CRISPR Therapeutics AG (CRSP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Salveen RichterGoldman Sachs Group, Inc., Research Division Raj, could you start by giving us a brief…

Tango Therapeutics: Combo Data With Revolution's RAS Inhibitor Whets Risk Appetite

Tango Therapeutics: Combo Data With Revolution's RAS Inhibitor Whets Risk Appetite#Tango #Therapeutics #Combo #Data #Revolution039s #RAS…

Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis – Slideshow

Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis…

Grace Therapeutics: Assessing The Path Forward For GTx-104

Grace Therapeutics: Assessing The Path Forward For GTx-104#Grace #Therapeutics #Assessing #Path #GTx104

PYC Therapeutics Limited (PYCXF) Shareholder/Analyst Call Transcript

PYC Therapeutics Limited (PYCXF) Shareholder/Analyst Call Transcript#PYC #Therapeutics #Limited #PYCXF #ShareholderAnalyst #Call #Transcript

Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise

Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise#Relay #Therapeutics #Zovegalisib #Platform #Disguise

Halozyme Therapeutics: Royalty King

Halozyme Therapeutics: Royalty King#Halozyme #Therapeutics #Royalty #King

Nektar Therapeutics (NKTR) Q1 2026 Earnings Call Transcript

Operator Hello and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2026…

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value#Janux #Therapeutics #Strong #Buy #Pipeline…